John Muir/Mt Diablo Health Syst
1400 Treat Boulevard
Walnut Creek, CA, United States
94596
1400 Treat Boulevard
Walnut Creek, CA, United States
94596
9259393000
No Website Provided
Facility Affiliations
Dr. Rona Z. Silkiss' Credentials
Accepting New Patients
Yes, this doctor is accepting new patients
Languages
- Spanish
Education
- Northwestern University Medical School (Grad. 1980)
Other Specialties
Areas of Expertise
- Entropion
- Graves' disease
- Bags under eyes
- Basal cell carcinoma
- Cosmetic Botox
- Ectropion
Publications & Research
- Neuroanatomic Variations in Graves' Dysthyroid Ophthalmopathy as Studied With MRI. Silkiss RZ, Wade AR. Trans Am Ophthalmol Soc. 2016 Aug;114:T9. Epub 2017 May 24.
- Receptor expression in orbital inflammatory syndromes and implications for targeted therapy. Ho VH, Chevez-Barrios P, Jorgensen JL, Silkiss RZ, Esmaeli B. Tissue Antigens. 2007 Aug;70(2):105-9. Erratum in: Tissue Antigens. 2008 Feb;71(2):185. Silkis, R
- Clinical Response to Tocilizumab in Severe Thyroid Eye Disease. Sy A, Eliasieh K, Silkiss RZ. Ophthalmic Plast Reconstr Surg. 2017 May/Jun;33(3):e55-e57
- Lenalidomide-Associated Thyroid-Related Eyelid Retraction. Slean GR, Silkiss RZ. Ophthalmic Plast Reconstr Surg. 2018 Mar/Apr;34(2):e46-e48.
- Hyaluronic acid gel (Restylane) filler for facial rhytids: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patients. McCracken MS, Khan JA, Wulc AE, Holds JB, Fante RG, Migliori ME, Ebroon DA
- THC:YAG nasolacrimal duct recanalization. Silkiss RZ. Ophthalmic Surg. 1993 Nov;24(11):772-4.
- Rituximab for thyroid eye disease. Silkiss RZ, Reier A, Coleman M, Lauer SA. Ophthalmic Plast Reconstr Surg. 2010 Sep-Oct;26(5):310-4.
- Highly active antiretroviral therapy-associated ptosis in patients with human immunodeficiency virus. Silkiss RZ, Lee H, Gills Ray VL. Arch Ophthalmol. 2009 Mar;127(3):345-6
- Indications and limitations of vismodegib for basal cell carcinoma--reply. Gill HS, Moscato EE, Silkiss RZ. JAMA Ophthalmol. 2014 Jul;132(7):906. doi: 10.1001/jamaophthalmol.2014.1805
- Autogenous fat grafting by injection. Silkiss RZ, Baylis HI. Ophthalmic Plast Reconstr Surg. 1987;3(2):71-5.
- Predicting the Development of Orbitopathy in Graves Thyroidopathy Patients: The Potential Role of TSI Testing. Takakura A, Kirkeby K, Earle K, Silkiss RZ. Ophthalmic Plast Reconstr Surg. 2015 Sep-Oct;31(5):369-7
- Vismodegib for periocular and orbital basal cell carcinoma. Gill HS, Moscato EE, Chang AL, Soon S, Silkiss RZ. JAMA Ophthalmol. 2013 Dec;131(12):1591-4
- Transcanalicular THC:YAG dacryocystorhinostomy. Silkiss RZ, Axelrod RN, Iwach AG, Vassiliadis A, Hennings DR. Ophthalmic Surg. 1992 May;23(5):351-3.
- Orbital B-lymphocyte depletion in a treatment failure of rituximab for thyroid eye disease. Gess AJ, Silkiss RZ. Ophthalmic Plast Reconstr Surg. 2014 Jan-Feb;30(1):e11-3
- New onset of keratoacanthomas after vismodegib treatment for locally advanced basal cell carcinomas: a report of 2 cases. Aasi S, Silkiss R, Tang JY, Wysong A, Liu A, Epstein E, Oro AE, Chang AL. JAMA Dermatol. 2013 Feb;149(2):242-3
- Gene Expression Profiling and Heterogeneity of Nonspecific Orbital Inflammation Affecting the Lacrimal Gland. Rosenbaum JT, Choi D, Harrington CA, Wilson DJ, Grossniklaus HE, Sibley CH, Salek SS, Ng JD, Dailey RA, Steele EA, Hayek B, Craven CM, Edward DP
- Evidence of orbital B and T cell depletion after rituximab therapy in Graves' ophthalmopathy. Nielsen JF, El Fassi D, Nielsen CH, Hegedüs L, Lauer SA, Silkiss RZ, Prause JU. Acta Ophthalmol. 2009 Nov;87(8):927-9
- Evidence of intrathyroidal B-lymphocyte depletion after rituximab therapy in a patient with Graves' disease. El Fassi D, Clemmensen O, Nielsen CH, Silkiss RZ, Hegedüs L. J Clin Endocrinol Metab. 2007 Oct;92(10):3762-3.
- Revascularization studies of an opposing eyelid pedicle flap. Silkiss RZ, Glasgow BJ, Baylis HI. Ophthalmic Plast Reconstr Surg. 1989;5(2):110-7.
- Inflammatory Mediators in Xanthelasma Palpebrarum: Histopathologic and Immunohistochemical Study. Govorkova MS, Milman T, Ying GS, Pan W, Silkiss RZ. Ophthalmic Plast Reconstr Surg. 2018 May/Jun;34(3):225-23
Insurance accepted by this Doctor
Other patients have successfully used these insurance providers, please call the Doctor's office to find out if your insurance plan is accepted.
Blue Cross / Blue Shield
Medicare
had treatment for a blocked tear duct. the office staff merits no stars. no info about drugs to be picked up at pharmacy. never had a returned phone call; the answering device comes on immediately. both visits had exhaustive waits. the procedure visit had a wait of 2 hours with no message forthcoming. the stent inserted by silkiss came loose the next morning. i called the emergency line and was directed to walnut creek. no address given. silkiss has 2 offices there. the written info from her staff did not have the address needed. more lack of communication. based on my experience with this md & the office crew, i would NOT recommend them for professional service. be forewarned!
Submitted Oct. 24, 2023